Clinical Trials Logo

Soft Tissue Bleeding clinical trials

View clinical trials related to Soft Tissue Bleeding.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05944419 Completed - Bone Resorption Clinical Trials

Influence of Neck Design on Peri-implant Hard and Soft Tissues

Start date: June 15, 2016
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test two different implant neck designs in 36 patients. The main question[s] it aims to answer are: - do triangular neck designed implants placed immediately after dental extraction have the same influence on peri-implant hard and soft tissues than regular neck designed implants at one year? - do triangular neck designed implants placed immediately after dental extraction have the same influence on peri-implant hard and soft tissues than regular neck designed implants at three years? Participants that present an unrepairable tooth on the anterior upper maxilla will be asked to take a CBCT scan in order to verify the presence of the buccal bone. Once this is verified the patients will enter in the study and the day of the surgery they will be assigned to either control or test group. - Control group: C1 round-neck implant - Test groups: V3 triangular-implant neck Researchers will compare test and control groups to see if they have the same effects on hard and soft tissues at 4 months, 1 year and 3 years.

NCT ID: NCT03819244 Completed - Postoperative Pain Clinical Trials

Comparison of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Start date: November 27, 2017
Phase: N/A
Study type: Interventional

The study evaluates postoperative pain, intraoperative bleeding and wound healing after second stage implant surgery. Submerged implants were exposed with diode laser in Group 1 (n=20) and by using Er,Cr:YSGG laser in Group 2 (n=20).

NCT ID: NCT02227992 Completed - Hemorrhage Clinical Trials

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Start date: July 1, 2014
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of EVARREST™ Sealant Matrix (EVARREST™ Fibrin Sealant Patch) (EVARREST™) in controlling mild or moderate soft tissue & parenchymal bleeding during open hepatic, abdominal, pelvic, retroperitoneal, and thoracic (non-cardiac) surgery in paediatric patients.

NCT ID: NCT02227706 Completed - Hemorrhage Clinical Trials

The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study

Start date: August 1, 2014
Phase: Phase 3
Study type: Interventional

To evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) as an adjunct to achieve haemostasis during surgery in paediatric patients.

NCT ID: NCT01902459 Completed - Hemorrhage Clinical Trials

EVARREST™ Fibrin Sealant Patch Post-Market Study

EVARREST
Start date: July 1, 2013
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.

NCT ID: NCT00977925 Completed - Clinical trials for Soft Tissue Bleeding

The Severe Soft Tissue Bleeding Study

Start date: August 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and hemostatic effectiveness of the Fibrin Pad (FP) versus standard of care treatment (SoC) in controlling challenging severe soft tissue bleeding during abdominal, pelvic, retroperitoneal, and (non-cardiac) thoracic surgery.